Search - tctmd.com

Displaying 1 - 3 of 3

Sort: Relevancy | Date

Presentation AHA 2018

Safety and Efficacy of AKCEA-APO(a)-LRx to Lower Lipoprotein(a) Levels in Patients With Established Cardiovascular Disease: A Phase 2 Dose-Ranging Trial

Presenter: Sotirios Tsimikas

November 11, 2018

News Conference News AHA 2018

November 11, 2018

News Conference News AHA 2016

November 15, 2016

Country

First Name

Last Name

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.